Vivek Ramaswamy (Jeff Rumans/JPM 2020)
Further setting the stage for going public, Vivek Ramaswamy’s Roivant readies a deal to buy up a Vant’s stock — cheap
Vivek Ramaswamy’s Roivant is in the process of reeling back in the chunk of shares it doesn’t already own in its subsidiary Immunovant ahead of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
